HOME | OUR COMPANY | PRODUCT PORTFOLIO | PRESS ROOM| INVESTORS | CAREERS | CONTACT US
SITE MAP | TERMS OF USE | PRIVACY POLICY

emergent biosolutions logo
Home Page
Our Company
spi-VEC TM
About spi-VEC
MVAtor TM

Key Benefits of spi-VECTM Oral Delivery Platform

  • Safety – Live attenuated bacterial vector has shown a promising safety profile to date in clinical trials of both adults and children
  • Oral Delivery – Drinkable vaccine that can be self administered
  • Immunogenicity – Designed to induce mucosal and systemic immune response
  • Versatility – All-purpose vaccine vector technology designed to deliver a wide range of antigens to prevent/ treat numerous diseases
  • Commercial Scale Process – A general cGMP manufacturing process for a stable, lyophilized product has been developed

spi-VEC is a trademark registered in the European Community and owned by Emergent.

OUR COMPANY Product Portfolio Press Room INVESTORS CAREERS CONTACT US